JOINN and BravoBio officially signed a Strategic Cooperation Agreement
Author:博沃管理员 Release time:2022-03-17 09:48:30
March 16, 2022 — JOINN Laboratories (China) Co., Ltd. (“JOINN Laboratories”), Beijing JOINN Biologics Co., Ltd. (“JOINN Biologics”), JOINN Clinical (Beijing) Co., Ltd. (“JOINN Clinical”), and Shanghai BravoBio Co., Ltd (“BravoBio”) today announced that the four parties have officially signed a Strategic Cooperation Agreement, becoming cooperative partners in vaccine R&D, evaluation and clinical research.
BravoBio is expecting to utilize JOINN’s integrated platforms and broad experience under this partnership, mobilize key resources from both JOINN and BravoBio, to expedite the development of vaccine candidates and move the vaccine pipelines into clinical stage in the fastest time possible.
Under the Agreement, JOINN will leverage its extensive experience in clinical research to support the development, evaluation and IND application for BravoBio’s multiple innovative vaccine candidates. BravoBio will utilize JOINN’s one-stop services from vaccine development, commercial manufacturing and clinical research, to achieve the seamless progression from vaccine R&D up to clinical stage.
Shanghai BravoBio Co., Ltd (BravoBio) was established in Zhangjiang Hi-Tech Park in Shanghai in March 2011 and moved to North Shanghai Biopharma Park in October 2021. Its subsidiary company, BravoVax, is a “state level high-tech enterprise” and a council member of China Association of Vaccines (CAV). It was awarded as “China Rising Star” by Deloitte in 2020, becoming the only vaccine company to win this award. The company boasts a number of advanced technology platforms, including gene editing / construction / cloning / detection, large-scale bacterial / cell / virus culture, preparation of bioactive substances (polysaccharide, protein, virus, etc.), conjugation of polysaccharide and protein, novel adjuvant, new process and analytical assays, etc. to meet the needs of developing innovative biologics, especially vaccines. BravoBio has held the mission to improve the quality of people’s lives, aiming for a healthier and happier future.
About JOINN Laboratories
Founded in 1995, JOINN Laboratories (China) Co., Ltd. (JOINN Laboratories, Stock Code: 603127.SSE/6127.HK) is dedicated to providing drug R&D CRO outsourcing services with over 2000 professionals. Headquartered in Beijing, JOINN has subsidiaries in Beijing, Suzhou, Shanghai, Chongqing, Wuzhou and Guangzhou in China, and Richmond (CA) and Worcester (MA) in the United States. JOINN has built a thorough quality management system complied with international standards: CNAS/ILAC-MRA certification, NMPA, US FDA, OECD, Japan PMDA and Korean MFDS GLP certification and international AAALAC accreditation. JOINN can provide customized services tailored to the client’s specific needs for non-clinical safety assessments, clinical trials, registrations, and pharmacovigilance which cover the entire spectrum from development to final drug registration. JOINN also provides services in animal feed and veterinary medicine evaluation, pesticide evaluation, medical device evaluations, and more.
About JOINN Clinical
About JOINN Biologics
JOINN Biologics, founded in 2018, is a full-service premier Contract Development & Manufacturing Organization which provides clients with quality, value and speed to market from DNA to Drug Product.